Hyunjun Choe

Hyunjun Choe is a Senior Scientist II at Arrowhead Pharmaceuticals, focusing on antibody development for siRNA delivery since October 2022. Previously, Hyunjun served as a Postdoctoral Research Fellow at The University of Texas Health Science Center at Houston, where contributions included the discovery of broadly neutralizing human mAbs and the identification of scFv antibodies for HLA-A2/CT83. Prior experience includes a role as a Postdoctoral Scholar at the University of California, Riverside, developing synthetic antibody libraries, as well as a Graduate Student at the University of Florida, where Hyunjun enhanced serine palmitoyltransferase substrate range. Educational qualifications include a PhD in Chemistry from the University of Florida and Master's and Bachelor's degrees in Chemical Engineering and Chemistry, respectively, from Kwangwoon University, where early research efforts involved biocatalyst development and characterization.